BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:My excursions into the world of medicine. A few examples from the 
 lab to the clinic.
DTSTART:20190212T171500
DTSTAMP:20260916T044107Z
UID:6bfa792ffee91358694b21734ad3f9982d5d177a4060819b4453ab53
CATEGORIES:Inaugural lectures - Honorary Lecture
DESCRIPTION:Prof. Hubert van den Bergh\nLEÇON D'HONNEUR / HONORARY LECTUR
 E\n\nRésumé / Abstract:\nI will describe our contributions to the develo
 pment of (1) the drug FOSCAN for  photodynamic treatment of head and nec
 k cancer\, and cancer of the esophagus and bronchi\, (2) the  autofluore
 scence bronchoscope DAFE for detection of small bronchial cancers\, (3) th
 e drug HEXVIX (CYSVIEW in the USA) for the detection and quantitative remo
 val of early stage bladder cancer (about 50'000 patients are being treate
 d/year)\, and (4) VISUDYNE technology in ophthalmology\, the first  effe
 ctive treatment for  wet Age-related Macular Degeneration and Polypoidal
  Choroidal Vasculopathy (several million patients have already been treat
 ed). To conclude I will discuss our laser-based method to separate isotope
 s for use in nuclear medicine.\n\nShort Bio:\nEducation: BA chemistry Will
 iams College Mass. USA\, MSc chemistry Univ. of California USA\, PhD physi
 cal chemistry Univ. of Cambridge UK\, Postdoc physics Max Planck Inst. Gö
 ttingen Germany. Moved to EPFL in 1973. \nTeaching: Chemical kinetics in 
 the department of chemistry\; Air pollution\, Weather and Climate courses 
 in the department of Rural Engineering. Elected one of the two best teach
 ers in my faculty.\nResearch: Contributions to Chemical Kinetics\, Air and
  Soil Pollution studies\, Laser Chemical Vapor Deposition\, Laser isotope 
 Separation\, and Photomedicine. The Photomedicine research led to several
  drugs and instruments now used world-wide to detect and treat cancer (abo
 ut 50’000 patients/year)\, and to treat wet Age-related Macular Degenera
 tion and PCV (several million patients already treated). 300+ publication
 s\, 22 patents.\nAdministration:  20 years at Swiss National Science Fou
 ndation: div. II and div. careers\, Head of EPFL’s GR department\, Head 
 of EPFL’s professorial promotions committee\, Head evaluator of Germany
 ’s Cancer Research Center (DKFZ clinical).\n\nProgramme:\n\n	Ouverture d
 e la Leçon par le Président EPFL\, Prof. Martin Vetterli\n	Brève interv
 ention par le Prof. D. Andrew Barry\, Doyen a.i. ENAC\n	Leçon d'honneur d
 u Prof. Hubert van den Bergh\n	Apéro\n\n\nInscription requise: https://go
 o.gl/forms/AkypOY7zvNEwl9z63 \n 
LOCATION:EPFL\, Auditoire CM 1 https://plan.epfl.ch/?room==CM%201%201
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR
